Sun Pharma to Acquire Checkpoint Therapeutics
Press Releases
March 10, 2025

Sun Pharma to Acquire Checkpoint Therapeutics

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for

bradford

The Bradford Era

Local & Social